Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease

A di Domenico, G Carola, C Calatayud… - Stem cell reports, 2019 - cell.com
Parkinson's disease (PD) is associated with the degeneration of ventral midbrain
dopaminergic neurons (vmDAns) and the accumulation of toxic α-synuclein. A non-cell …

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013 …

CJL Murray, RM Barber, KJ Foreman, AA Ozgoren… - The Lancet, 2015 - thelancet.com
Summary Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring
together all available epidemiological data using a coherent measurement framework …

Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial

EJ Daly, JB Singh, M Fedgchin, K Cooper, P Lim… - JAMA …, 2018 - jamanetwork.com
Importance Approximately one-third of patients with major depressive disorder (MDD) do not
respond to available antidepressants. Objective To assess the efficacy, safety, and dose …

[HTML][HTML] Reassessing the host defense peptide landscape

EF Haney, SK Straus, REW Hancock - Frontiers in chemistry, 2019 - frontiersin.org
Current research has demonstrated that small cationic amphipathic peptides have strong
potential not only as antimicrobials, but also as antibiofilm agents, immune modulators, and …

A global view of pulmonary hypertension

MM Hoeper, M Humbert, R Souza, M Idrees… - The Lancet …, 2016 - thelancet.com
Pulmonary hypertension is a substantial global health issue. All age groups are affected with
rapidly growing importance in elderly people, particularly in countries with ageing …

Diabetes in sub-Saharan Africa: from clinical care to health policy

R Atun, JI Davies, EAM Gale… - The lancet Diabetes & …, 2017 - thelancet.com
Executive summary Rapid demographic, sociocultural, and economic transitions are driving
increases in the risk and prevalence of diabetes and other non-communicable diseases …

Global prevalence of chronic kidney disease–a systematic review and meta-analysis

NR Hill, ST Fatoba, JL Oke, JA Hirst, CA O'Callaghan… - PloS one, 2016 - journals.plos.org
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health
systems and is an independent risk factor for cardiovascular disease (CVD). All stages of …

Individual differences in pain: understanding the mosaic that makes pain personal

RB Fillingim - Pain, 2017 - journals.lww.com
It has long been appreciated that individuals differ from each other in important ways. More
than 2000 years ago, Plato said:“No 2 persons are born exactly alike; but each differs from …

Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries

AF Jorm, SB Patten, TS Brugha, R Mojtabai - World Psychiatry, 2017 - Wiley Online Library
Many people identified as having common mental disorders in community surveys do not
receive treatment. Modelling has suggested that closing this “treatment gap” should reduce …

Disability weights for the Global Burden of Disease 2013 study

JA Salomon, JA Haagsma, A Davis… - The Lancet Global …, 2015 - thelancet.com
Summary Background The Global Burden of Disease (GBD) study assesses health losses
from diseases, injuries, and risk factors using disability-adjusted life-years, which need a set …